There is a significant positive association between dietary calcium intake and benign prostatic hyperplasia (BPH), according to a study published online May 30 in Translational Andrology and Urology.

The purpose of this manuscript is to provideclinicians, health plan decision makers, and policymakers with highlights of key findings pertainingto our current understanding of the condition ofenlarged ...

Entadfi is a fixed-dose combination of finasteride, a 5α-reductase inhibitor, and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor. The Food and Drug Administration (FDA) has approved Entadfi ...

Extracts of the berries of saw palmetto, a small palm tree native to the southeastern U.S., are used widely to treat benign prostatic hyperplasia (BPH). In this randomized trial conducted in ...

Dr. R K Shimpi explains Benign Prostatic Hyperplasia (BPH) and Overactive Bladder (OAB), their symptoms, causes, and modern ...

Benign prostatic hyperplasia (BPH) is a prevalent condition characterised by the non-malignant enlargement of the prostate gland, which frequently precipitates lower urinary tract symptoms (LUTS).

Investigators compared prostatic artery embolization against a combination of an alpha blocker and 5-alpha reductase inhibitor for BPH. Prostatic artery embolization (PAE) yields greater clinical ...

Patients with gout, especially those younger than 60 years, have an increased risk for benign prostatic hyperplasia (BPH), according to a study published online Dec. 26 in Diagnostics. Woo Jin Bang, ...

Widely used medications for benign prostatic hyperplasia (BPH) - also known as enlarged prostate - may be associated with a small, but significant increase in the probability of developing heart ...

Drug Used for Enlarged Prostate Tied to High Glaucoma Risk The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study ...